Israel IVF startup looks to democratize infertility coverage in the United States
May 19, 2023
“While AI is spurring success, barriers to treatment remain, says Daniella Gilboa, CEO of AIVF.”
Disclaimer: EMA by AIVF has CE mark. In the US, an AI component of EMA is considered an investigational device. Limited by Federal (or United States) law to investigational use.
©All rights reserved AIVF 2023